Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years

Moshe S. Weintraub, Itamar Grosskopf, Toby Rassin, Hylton Miller, Gideon Charach, Heschi H. Rotmensch, Meir Liron, Ardon Rubinstein, Adrian Iaina

Research output: Contribution to journalArticlepeer-review

Abstract

Objective - To test the hypothesis that subjects who clear chylomicron remnants slowly from plasma may be at higher risk of coronary artery disease than indicated by their fasting plasma lipid concentrations. Design - Case control study over three years. Setting - An 800 bed general municipal hospital. Subjects - 85 normolipidaemic patients with coronary artery disease selected prospectively and matched with 85 normolipidaemic subjects with normal coronary arteries on angiography. Interventions - All subjects were given a vitamin A fat loading test which specifically labels intestinal lipoproteins with retinyl palmitate. Main outcome measure - Postprandial lipoprotein metabolism. Results - The area below the chylomicron remnant retinyl palmitate curve was significantly increased in the coronary artery disease group as compared with the controls (mean 23.4 (SD 15.0) v 15.3 (8.9) μmol/l.h; 95% confidence interval of difference 4.37 to 11.82). Conclusions - Normolipidaemic patients with coronary artery disease had significantly higher concentrations of chylomicron remnants in plasma than normolipidaemic subjects with normal coronary vessels. This may explain the mechanism underlying the susceptibility to atherosclerosis of coronary artery disease patients with normal fasting lipid values. As diet and drugs can ameliorate the accumulation of postprandial lipoproteins in plasma, the concentration of chylomicron remnants should be measured in patients at high risk of coronary artery disease.

Original languageEnglish
Pages (from-to)935-939
Number of pages5
JournalThe BMJ
Volume312
Issue number7036
DOIs
StatePublished - 1996

Fingerprint

Dive into the research topics of 'Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years'. Together they form a unique fingerprint.

Cite this